Hsp90 Inhibitor AUY922 in Treating Older Patients With Advanced Solid Malignancies

NCT01602627 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped Slow accrual

Conditions

Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG: Hsp90 inhibitor AUY922
OTHER: pharmacological study
OTHER: laboratory biomarker analysis

Sponsor

Dale Shepard, MD, PhD

Collaborators

[object Object]